Scientists identify new pathogenic and protective microbes associated with severe diarrhea

Key points
- These microbes were not widely linked to the condition previously.
- The University of Maryland is the state's flagship university and one of the nation's preeminent public research universities.
- Established in 1807, The School of Medicine is the first public and the fifth oldest medical school in the United States, and the first to institute a residency-training program.
- "We were able to identify interactions between microbiota that were not previously observed, and we think that some of those interactions may actually help prevent the onset of severe diarrhea," says O.
In a finding that may one day help control a major cause of death among children in developing countries, a team of researchers led by faculty from the University of Maryland, College Park and the University of Maryland School of Medicine has identified microorganisms that may trigger diarrheal disease and others that may protect against it. These microbes were not widely linked to the condition previously.
"We were able to identify interactions between microbiota that were not previously observed, and we think that some of those interactions may actually help prevent the onset of severe diarrhea," says O. Colin Stine, a professor of epidemiology and public health at the University of Maryland School of Medicine.
A much better understanding of these interactions is important, Stine adds, as they could lead to possible dietary interventions. Moderate to severe diarrhea (MSD) is a major cause of childhood mortality in developing countries and ranks as one of the top four causes of death among young children in sub-Saharan Africa and South Asia.
Stine and Mihai Pop, an associate professor of computer science at the University of Maryland, College Park led the six-year project funded by $10.1 million from the Bill & Melinda Gates Foundation. The research results are available in a paper published today in the journal Genome Biology.
The researchers used a technique called high-throughput 16S rRNA genomic sequencing to examine both "good" and "bad" microbiota - the tens of trillions of microbes that inhabit the human intestinal system - in samples taken from 992 children in Bangladesh, The Gambia, Kenya and Mali under the age of 5 who were suffering from MSD.
The researchers identified statistically significant disease associations with several organisms already implicated in diarrheal disease, such as members of the Escherichia/Shigella genus and Campylobacter jejuni. They also found that organisms not widely believed to cause the disease, including Streptococcus and Granulicatella, correlated with the condition in their study. In addition, the study revealed that the Prevotella genus and Lactobacillus ruminis may play a protective role against diarrhea.
The project is an offshoot of a $20 million study commissioned by the Gates Foundation in 2006. The Global Enterics Multicenter Study (GEMS) was launched in response to unanswered questions surrounding the burden and etiology of childhood diarrhea in developing countries.
GEMS collected troves of useful data on MSD, yet there were still some uncertainties, says Pop, who also has an appointment in the University of Maryland Institute for Advanced Computer Studies.
For example, in almost 50 percent of the children examined with diarrhea, the condition could not be attributed to a specific causal pathogen. The GEMS research also found numerous children carrying Shigella, which is known to cause problems, yet the children showed no signs of MSD.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Digestive Health →
GuideTumor Necrosis Factor-Alpha (TNF- α) Inhibitors
TNF- α is a pro-inflammatory cytokine that plays a pivotal role in the pathogenesis of IBD and has been found in increased concentrations in the mucosa and stool of patients with Crohn's disease. There are currently…
27 August 2015
GuideMedical Therapy for Crohn's Disease: The Present
Treatment options for Crohn's disease have been developing and expanding rapidly over the past 10 years. Multiple classes of medications are currently available to treat Crohn's disease, including 5-aminosalicylates…
27 August 2015
GuideCrohn and Ginzburg and Oppenheimer (CGO) and Beyond
To understand the historical evolution of the disease, a review of its initial definition is critical. In 1932, Crohn, Ginzburg, and Oppenheimer identified 14 cases of inflammatory disease of the terminal ileum which…
26 August 2015